A new study aimed to examine associations between dietary patterns and survival among Black women diagnosed with epithelial ...

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.

A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ...

Ovarian cancer affects thousands of women in the UK each year and is known as the 'silent killer' because its symptoms can be ...

Tumours shrank or stopped growing in almost one in three women (31 per cent) with low-grade serous ovarian cancer, which does ...

Higher levels of ambient nitrogen dioxide may be linked to an increased incidence of ovarian cancer, while associations with ...

Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to ...

Professor Susana Banerjee, from the Royal Marsden NHS Foundation Trust and the Institute of Cancer Research said the findings ...

Scientists say the Royal Marsden hospitals' drug trial could change practice globally for serous form of ovarian cancer which ...

Scientists at the University of Oxford have started developing the world's first ovarian cancer vaccine. It could be a game ...